SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-16-006799
Filing Date
2016-08-12
Accepted
2016-08-12 16:06:20
Documents
49
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT vtgn10q_jun202016.htm 10-Q 1096327
2 CERTIFICATION ex31-1.htm EX-31.1 11742
3 CERTIFICATION ex31-2.htm EX-31.2 11802
4 CERTIFICATION ex32.htm EX-32 5865
  Complete submission text file 0001415889-16-006799.txt   3105605

Data Files

Seq Description Document Type Size
5 vsta-20160630.xml EX-101.INS 444387
6 vsta-20160630.xsd EX-101.SCH 39857
7 vsta-20160630_cal.xml EX-101.CAL 38878
8 vsta-20160630_def.xml EX-101.DEF 100339
9 vsta-20160630_lab.xml EX-101.LAB 222122
10 vsta-20160630_pre.xml EX-101.PRE 152588
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 161828257
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences